We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKM:NYSESK Telecom Co., Ltd. Analysis

Data as of 2026-05-01 - not real-time

$37.41

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SK Telecom’s ADR is trading at $37.41, comfortably above its 20‑day (≈36.10) and 50‑day (≈32.32) moving averages, indicating a short‑term bullish bias, while the 30‑day RSI sits at 63, suggesting momentum is still strong but edging toward overbought territory. The MACD histogram has turned negative and the signal line is bearish, hinting at a possible near‑term pullback despite the overall bullish trend direction and increasing volume. Volatility is elevated at roughly 44% over the past month, yet the stock’s beta of 0.32 points to low systematic risk relative to the market.
Fundamentally, the stock appears overvalued: a trailing P/E of 54 × dwarfs the industry average of 19 ×, and the current price exceeds the consensus target range of $28‑$28.65, implying a downside of over 20%. Forward earnings improve the picture (forward P/E ≈16.5 ×), but the dividend payout ratio of 149% raises sustainability concerns, especially given a debt‑to‑equity ratio above 80 and modest ROE of 3%. Revenue is contracting (‑4 % YoY) and profit margins remain thin, while analyst sentiment is “underperform.” The market’s extreme greed reading (90.9) further suggests pricing optimism may be overstretched.
Given the mixed technical signals, high valuation, and balance‑sheet pressure, the short‑term stance is cautious hold, the medium‑term outlook leans toward a sell recommendation, and the long‑term view remains neutral pending a price correction and clearer earnings trajectory.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages but MACD turning bearish
  • High volatility with low beta
  • Increasing volume supporting current trend

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Trailing P/E far above industry average
  • Consensus target price ~28 USD indicating sizable downside
  • Elevated debt‑to‑equity and unsustainable dividend payout

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward P/E suggests potential value if earnings materialize
  • AI data‑center collaboration could drive future growth
  • Current valuation gap may correct, offering entry at lower levels

Key Metrics & Analysis

Financial Health

Revenue Growth-4.10%
Profit Margin2.39%
P/E Ratio54.2
ROE3.03%
ROA2.21%
Debt/Equity80.07
P/B Ratio1.7
Op. Cash Flow$3923.8B
Free Cash Flow$332.2B
Industry P/E18.9

Technical Analysis

TrendBullish
RSI63.4
Support$28.50
Resistance$40.49
MA 20$36.10
MA 50$32.32
MA 200$24.70
MACDBearish
VolumeIncreasing
Fear & Greed Index90.93

Valuation

Target Price$28.65
Upside/Downside-23.41%
GradeOvervalued
TypeBlend
Dividend Yield3.74%

Risk Assessment

Beta0.32
Volatility43.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.